Read APC's joint comment letter with the National Community Pharmacists Association regarding HHS' interim peptide policy, submitted on November 13 – supporting the policy and essentially seeking some clarifications and a temporary sourcing safeguard while manufacturers of the covered peptide APIs establish and demonstrate compliance with the policy’s testing and quality requirements.